Zoe M Koerperich

5PUBLICATIONS
12CO-AUTHORS
Molecular medicineCharacterisation of biological macromoleculesComparative and cross-cultural educationBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 18, 2024
Incorporation of Three Extracyclic Arginine Residues into a Melanocortin Macrocyclic Agonist (c[Pro-His-DPhe-Arg-Trp-Dap-Lys(Arg-Arg-Arg-Ac)-DPro]) Decreases Food Intake When Administered Intrathecally or Subcutaneously Compared to a Macrocyclic Ligand Lacking Extracyclic Arginine Residues (c[Pro-His-DPhe-Arg-Trp-Dap-Ala-DPro)].

Mark D Ericson, Katie T Freeman, Courtney M Larson

|Oct 01, 2021
Functional Mixture-Based Positional Scan Identifies a Library of Antagonist Tetrapeptide Sequences (LAtTeS) with Nanomolar Potency for the Melanocortin-4 Receptor and Equipotent with the Endogenous AGRP(86-132) Antagonist.

Mark D Ericson, Skye R Doering, Courtney M Larson

|Aug 22, 2020
Comparative Intracerebroventricular and Intrathecal Administration of a Nanomolar Macrocyclic Melanocortin Receptor Agonist MDE6-5-2c (c[Pro-His-DPhe-Arg-Trp-Dap-Ala-DPro]) Decreases Food Intake in Mice.

Danielle N Adank, Mary M Lunzer, Mark D Ericson

|Jan 09, 2020
Journeying through the Field of Medicinal Chemistry: Perspectives from Graduate Researchers.

Zoe M Koerperich, Samantha A Kennelly, Connor M McDermott

|Dec 18, 2019
Incorporation of Agouti-Related Protein (AgRP) Human Single Nucleotide Polymorphisms (SNPs) in the AgRP-Derived Macrocyclic Scaffold c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-dPro] Decreases Melanocortin-4 Receptor Antagonist Potency and Results in the Discovery of Melanocortin-5 Receptor Antagonists.

Zoe M Koerperich, Mark D Ericson, Katie T Freeman

Pageof 1

Frequent Collaborators

4 joint publications

Carrie Haskell-Luevano

2 joint publications

Mark D Ericson

1 joint publications

Henry I Mosberg

1 joint publications

Samantha A Kennelly